Timothy G.Hoxie

Of Counsel

San Francisco + 1.415.875.5810

Tim Hoxie has more than 30 years of experience counseling public and private clients on corporate governance, securities law compliance, mergers and acquisitions, joint ventures, and public and private debt and equity financing transactions. He represents clients in a variety of industries, including semiconductor equipment manufacturers, private equity investors (and in particular sovereign investors), health care enterprises, solar power companies, and professional services firms.

Tim's recent transactional experience includes public and private acquisitions, both domestic and cross-border. He has represented clients in creating substantial joint ventures and has counseled them in managing disputes with partners. His private equity representations involve work with or opposite leading private equity players throughout the country and overseas, as well as representation of investors in venture capital transactions.

Tim is a member of the State Bar of California and the American Bar Association, and he has chaired numerous business law committees within each organization. He is a past chair of the California State Bar's Business Law Section and of its Corporations Committee, has served as co-chair of the section's Opinions Committee, is a past chair of the ABA Business Law Section Opinions Committee, and is a member of the Tri-Bar Opinions Committee. He is a director of the Working Group on Legal Opinions Foundation and is a past chair of the ABA Business Law Section's Committee on State and Local Bar Relations. He is a member of the Council of the ABA Business Law Section and a Fellow of the American Bar Foundation.

Experience

  • SunPower closes sponsored spin-off of solar panel production operationsJones Day advised SunPower Corporation (NASDAQ: SPWR), one of North America's largest solar-panel makers, in a sponsored spin-off of its solar panel production operations into a new public company – Maxeon Solar Technologies – which will be headquartered in Singapore.
  • UPMC subsidiary Curavi Health combined with CarePointe and U.S. Health Systems to form Arkos HealthJones Day advised University of Pittsburgh Medical Center (UPMC) in the business combination of its subsidiary Curavi Health, Inc. with CarePointe and U.S. Health Systems to form Arkos Health, a company that will provide virtual care solutions and health insights to vulnerable populations across the United States.
  • Lam Research completes $2 billion public offering of Senior NotesJones Day advised Lam Research Corporation, a global supplier of wafer fabrication equipment and services to the worldwide semiconductor industry, in connection with its underwritten public offering of $2 billion of Senior Notes, consisting of $750 million of 1.900% Senior Notes due 2030, $750 million of 2.875% Senior Notes due 2050, and $500 million of 3.125% Senior Notes due 2060.
  • Exponent sells German subsidiaryJones Day advised Exponent, Inc. in the sale of its German subsidiary, Exponent GmbH.
  • U.S. Steel acquires remaining 50% ownership interest in USS-POSCO Industries from POSCO-California CorporationJones Day advised United States Steel Corporation in its acquisition of POSCO-California Corporation's 50% partnership interest in USS-POSCO Industries, a Pittsburg, California-based producer of cold-rolled sheets, galvanized sheets, and tin mill products made from hot bands, resulting in USS-POSCO Industries becoming a wholly-owned subsidiary of U.S. Steel.
  • SunPower completes $169.6 million public offering of Common StockJones Day represented SunPower Corporation, a solar products and services company, in connection with the $169.6 million underwritten public offering of 22,000,000 shares of Common Stock.
  • Lam Research completes $2.5 billion public offering of Senior NotesJones Day advised Lam Research Corporation, a global supplier of wafer fabrication equipment and services to the worldwide semiconductor industry, in connection with its underwritten public offering of $2.5 billion of Senior Notes, consisting of $750 million of 3.750% Senior Notes due 2026, $1.0 billion of 4.000% Senior Notes due 2029, and $750 million of 4.875% Senior Notes due 2049.
  • Undisclosed investor participates in $550 million Series F financing round of PelotonJones Day represented an undisclosed investor in the $550 million Series F financing by Peloton Interactive, Inc., a global fitness technology company.
  • Dignity Health and Select Medical combine Concentra and U.S. HealthWorks for $753 millionJones Day advised Dignity Health in its $753 million sale of its U.S. HealthWorks, Inc. subsidiary to Concentra Group Holdings, LLC.
  • Lam Research acquires Coventor, Inc.Jones Day advised Lam Research Corporation in its acquisition of Coventor, Inc., a leading provider of simulation and modeling solutions for semiconductor process technology, micro-electromechanical systems (MEMS), and the Internet of Things (IoT).
  • CreditAccess Asia completes complex €95.4 million (US$102.8 million) multi-investor investment roundJones Day advised CreditAccess Asia, a micro-finance institution active primarily in India and SEA, on a complex €95.4 million (US$102.8 million) multi-investor investment round, involving (a) the conversion of outstanding bonds into equity; (b) the investment by Asian Development Bank, an international development bank; (c) the conversion of bonds held by a private equity fund Olympus Capital Asia; and (d) a further investment round by new investors.
  • Lam Research attempts merger with KLA-TencorJones Day represented Lam Research Corporation in its proposed acquisition of all outstanding shares of KLA-Tencor Corporation in a cash and stock transaction that placed an equity value on KLA-Tencor of approximately $10.6 billion based on its closing stock price on October 20, 2015.
  • Sycamore Hill Capital completes sale of Illume to Regent Holding Co.Jones Day represented Sycamore Hill Capital Group in connection with its sale of Illume, a distributor of home fragrance and beauty products, to Regent Holding Co.
  • SunPower issues $425 million of 4.00% Senior Convertible Debentures in Rule 144A offeringJones Day represented SunPower Corporation, a vertically integrated solar products and services company, in connection with its issuance of $425 million of 4.00% Senior Convertible Debentures due 2023 in a Rule 144A offering.
  • Lam Research completes $1 billion Senior Notes offeringJones Day represented Lam Research Corporation, a leading supplier of wafer fabrication equipment and services to the worldwide semiconductor industry, in connection with its public offering of $500 million of 2.750% Senior Notes due 2020 and $500 million of 3.800% Senior Notes due 2025 through underwriters led by joint book-running managers J.P. Morgan Securities LLC and Merrill Lynch, Pierce, Fenner & Smith Incorporated.
  • Fortune 500 life sciences company acquires medical device developerJones Day advised a Fortune 500 life sciences company in its acquisition of a developer of medical devices for approximately $250 million in cash.
  • Orange (France Telecom) sells Dominican Republic assets to Altice for $1.42 billion (€1.05 billion)Jones Day advised long-standing client Orange, S.A. (France Telecom), a leading global telecommunications company, in connection with the sale of 100 percent of Orange Dominicana S.A., its subsidiary in the Dominican Republic, to Altice, a multinational cable and telecommunications company, for $1.42 billion (€1.05 billion).
  • FriendFinder Networks noteholders take control of companyJones Day represented two individuals who held more than two thirds of $330 million in second lien notes issued by FriendFinder Networks, Inc.
  • Dignity Health purchases revenue cycle management services from Optum360Jones Day represented Dignity Health in negotiating a 10-year management services agreement with Optum360.
  • Dignity Health forms joint venture with Optum InsightJones Day advised Dignity Health, the fifth largest hospital provider in the United States, in the formation of a joint venture with Optum Insight, a provider of information and technology solutions in the health care field.
  • We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.